Skip Navigation


JAC Advance Access originally published online on July 11, 2007
Journal of Antimicrobial Chemotherapy 2007 60(3):662-664; doi:10.1093/jac/dkm257
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
60/3/662    most recent
dkm257v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mandomando, I.
Right arrow Articles by Alonso, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandomando, I.
Right arrow Articles by Alonso, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique

Inácio Mandomando1,2,*, Mateu Espasa1, Xavier Vallès1, Jahit Sacarlal1,3, Betuel Sigaúque1,2, Joaquim Ruiz4 and Pedro Alonso1,4

1 Centro de Investigação em Saúde da Manhiça (CISM), Maputo, Mozambique 2 Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique 3 Faculdade de Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique 4 Centre for International Health Research (CRESIB), Hospital Clinic/IDIBAPS, Universitat de Barcelona, Spain

Received 20 March 2007; returned 27 April 2007; revised 4 June 2007; accepted 20 June 2007

* Correspondence address. Manhiça Health Research Centre, Street 12, Manhiça Village, PO Box 1929, Maputo, Mozambique. Tel: +258-21-810-002; Fax: +258-21-810-181; E-mail: inacio.mandomando{at}manhica.net, imandomando2004{at}yahoo.com.br

Objectives: To describe the antimicrobial susceptibility profile of isolated Vibrio cholerae O1 serotype Ogawa recovered from patients admitted to the cholera facility in the Manhiça District Hospital (MDH), Mozambique.

Methods: Rectal swabs were collected from patients with complaints symptomatic of cholera admitted to the MDH cholera facility. Samples were processed for V. cholerae isolation at the Centro de Investigação em Saúde da Manhiça (CISM) and identified by biochemical reaction. Serotypes were determined by slide-agglutination antisera. Susceptibilities were determined by disc diffusion.

Results: Seventy-seven isolates were examined for their resistance profile. High incidences of antimicrobial resistance were found for chloramphenicol (57.9%), co-trimoxazole (96.6%) and tetracycline (97.3%). Quinolone resistance remained low (4.2%).

Conclusions: Although V. cholerae infections in Africa do not usually require antimicrobial treatment, strains in rural Mozambique show high incidences of resistance to readily available drugs. When appropriate, quinolones or third-generation cephalosporins can be used as treatment options.

Keywords: susceptibility profile , cholera , diarrhoea


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.